1. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

   • Paul Adams
   • Albert Altes
   • Contributors and Hemochromatosis International Taskforce

   Guidelines Open access 27 March 2018 Pages: 83 - 86

2. Spontaneous bacteremia and spontaneous bacterial peritonitis in cirrhosis: two infections but similar outcomes?

   • Rakhi Maiwall

   Editorial 27 March 2018 Pages: 87 - 89

3. Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response

   • Tatsuo Kanda
   • Shunichi Matsuoka
   • Mitsuhiko Moriyama

   Editorial 04 April 2018 Pages: 90 - 93

4. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination

   • Chih-Lin Lin
   • Jia-Horng Kao

   Editorial 04 April 2018 Pages: 94 - 96

   

5. Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis

   • Alexander J. Kovalic
   • Sanjaya K. Satapathy
   • Naga Chalasani

   Review Article 29 March 2018 Pages: 97 - 106

   

6. The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection

   • Fan Li
   • Xiaodong Li
   • Dongping Xu

   Original Article 12 April 2018 Pages: 107 - 117

   

7. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

   • Tianyu He
   • Yuqing Bai
   • Jidong Jia

   Original Article 17 January 2018 Pages: 118 - 125

   

8. Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study

   • Lai Wei
   • Qing Xie
   • Zhongping Duan

   Original Article Open access 10 April 2018 Pages: 126 - 132

9. Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

   • Tomomi Okubo
   • Masanori Atsukawa
   • Katsuhiko Iwakiri

   Original Article 29 March 2018 Pages: 133 - 142

   

10. High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy

    • Rasha Eletreby
    • Mohamed Said
    • Wahid Doss

    Original Article 14 February 2018 Pages: 143 - 148

11. Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation

    • Tomoki Ryu
    • Yuko Takami
    • Hideki Saitsu

    Original Article 27 February 2018 Pages: 149 - 157

    

12. Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis

    • Abhijit Chougule
    • Archana Rastogi
    • Shiv Kumar Sarin

    Original Article 12 April 2018 Pages: 158 - 166

    

13. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis

    • Ka Wing Ma
    • Kenneth Siu Ho Chok
    • Chung Mau Lo

    Original Article 15 February 2018 Pages: 167 - 173

    

14. Psychiatric comorbidities among patients undergoing liver transplantation in South Korea: a nationwide population-based study

    • Jaesung Heo
    • O Kyu Noh
    • Logyoung Kim

    Original Article 13 February 2018 Pages: 174 - 180

    

15. Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study

    • Sebastián Marciano
    • Melisa Dirchwolf
    • Adrián Gadano

    Original Article 09 December 2017 Pages: 181 - 190

    

16. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis

    • Keiichi Fujiwara
    • Yoshihiro Fukuda
    • Naoya Kato

    Original Article 15 February 2018 Pages: 191 - 199